Kevin J. Ontiveros
Keine laufenden Positionen mehr
Karriereverlauf von Kevin J. Ontiveros
Ehemalige bekannte Positionen von Kevin J. Ontiveros
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SINTX TECHNOLOGIES, INC. | Compliance Officer | 29.01.2013 | 08.01.2015 |
| General Counsel | 29.01.2013 | 08.01.2015 | |
| Unternehmenssekretär | 01.12.2012 | 08.01.2015 | |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | General Counsel | - | 11.06.2008 |
| Unternehmenssekretär | - | 11.06.2008 | |
| NPS PHARMACEUTICALS, INC. | General Counsel | 01.04.1996 | - |
Ausbildung von Kevin J. Ontiveros
| University of Florida | Graduate Degree |
| University of Arizona | Undergraduate Degree |
| S.J. Quinney College of Law | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| General Counsel | 3 |
| Corporate Secretary | 2 |
| Graduate Degree | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SINTX TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
- Börse
- Insiders
- Kevin J. Ontiveros
- Erfahrung
